Leukocytosis and thrombocytosis as prognostic factors for women with uterine cervical cancer

Y. Murata, Y. Miyahara, K. Suzuki, S. Wakahashi, T. Sudo, S. Nagao, S. Yamaguchi, Y. Ebina, H. Yamada

Research output: Contribution to journalArticlepeer-review


Purpose of Investigation: The aim of this study was to evaluate whether leukocytosis and thrombocytosis prior to treatment was associated with the prognosis of women with uterine cervical cancer. Materials and Methods: The authors assessed 2,267 women who were diagnosed as having FIGO Stages I-IV uterine cervical cancer and were followed up for at least five years. The age, clinical stage, histology, leukocytosis, and thrombocytosis at the initial diagnosis were evaluated for overall survival (OS). Results: Leukocytosis and thrombocytosis were identified in 315 and in 134 women, respectively. Fifty-eight had both conditions. Multivariable analysis revealed that age [hazard ratio (HR) 1.7, p < 0.001], advanced FIGO Stage (4.8, p < 0.001), histology (2.0, p < 0.001), leukocytosis (1.5, p < 0.01), and thrombocytosis (2.0, p < 0.01) were independent factors for decreased OS. OS of women with both thrombocytosis and leukocy-tosis was the worst (p < 0.01). Conclusion: Leukocytosis and thrombocytosis were independently associated with decreased OS in women with uterine cervical cancer.

Original languageEnglish
Pages (from-to)93-97
Number of pages5
JournalEuropean Journal of Gynaecological Oncology
Issue number1
Publication statusPublished - Feb 15 2020
Externally publishedYes


  • Cervical cancer
  • Leukocytosis
  • Prognosis
  • Thrombocytosis

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology


Dive into the research topics of 'Leukocytosis and thrombocytosis as prognostic factors for women with uterine cervical cancer'. Together they form a unique fingerprint.

Cite this